Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Prognostic factors in early-stage leiomyosarcoma of the uterus
Manuela Pelmus, Frédérique Penault-Llorca, Louis Guillou, et al.
Cancers
|
May 14, 2022
Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
Mathilde Mairé, Aurélien Bourdon, Isabelle Soubeyran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations
Sabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Bulletin Du Cancer
|
December 27, 2021
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer
Patricia Pautier, Thibault de la Motte-Rouge, Fabrice Lécuru, et al.
The American Journal of Surgical Pathology
|
July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas
Marie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
Drugs - Real World Outcomes
|
January 11, 2023
Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
Charlotte Bellier, Laurence Gladieff, Fanny Le Du, et al.
Nature Communications
|
June 4, 2024
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma
Frédéric Amant, Anne Floquet, Michael Friedlander, et al.
Nature Communications
|
March 5, 2024
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
Journal of Hematology & Oncology
|
February 10, 2017
Clinical impact of extensive molecular profiling in advanced cancer patients
Sophie Cousin, Thomas Grellety, Maud Toulmonde, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 2, 2009
Prognostic factors in early-stage leiomyosarcoma of the uterus
Manuela Pelmus, Frédérique Penault-Llorca, Louis Guillou, et al.
Cancers
|
May 14, 2022
Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
Mathilde Mairé, Aurélien Bourdon, Isabelle Soubeyran, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 20, 2013
YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations
Sabrina Croce, Isabelle Hostein, Agnes Ribeiro, et al.
Bulletin Du Cancer
|
December 27, 2021
Prise en charge médicale de la récidive du cancer épithélial de l'ovaire: Medical management of recurrent epithelial ovarian cancer
Patricia Pautier, Thibault de la Motte-Rouge, Fabrice Lécuru, et al.
The American Journal of Surgical Pathology
|
July 3, 2015
SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas
Marie Karanian-Philippe, Valérie Velasco, Michel Longy, et al.
Drugs - Real World Outcomes
|
January 11, 2023
Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
Charlotte Bellier, Laurence Gladieff, Fanny Le Du, et al.
Nature Communications
|
June 4, 2024
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 18, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma
Frédéric Amant, Anne Floquet, Michael Friedlander, et al.
Nature Communications
|
March 5, 2024
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
Gilles Freyer, Anne Floquet, Olivier Tredan, et al.
Journal of Hematology & Oncology
|
February 10, 2017
Clinical impact of extensive molecular profiling in advanced cancer patients
Sophie Cousin, Thomas Grellety, Maud Toulmonde, et al.
Page
of 10